News & Events

News

Scientists use computational modeling to guide a difficult chemical synthesis

Posted
June 27, 2024

Using this new approach, researchers could develop drug compounds with unique pharmaceutical properties.

Researchers from MIT and the University of Michigan have discovered a new way to drive chemical reactions that could generate a wide variety of compounds with desirable pharmaceutical properties.

These compounds, known as azetidines, are characterized by...

Event

CSB Thesis Defense: Sameed Siddiqui (Sabeti/Collins Lab)

Posted
June 6, 2024

CSB PhD Candidate: Sameed Siddiqui 

Faculty Advisors: Prof. Pardis Sabeti & Prof. James Collins

Date: Friday, June 7, 2024

Time: 2:00 PM EST

Room: 68-181

Thesis title: Serology, CRISPR Diagnostics, and Machine Learning Architectures for Biological Sequences

Abstract: Fueled by technological breakthroughs, advancements in our understanding of infectious agents offer unprecedented potential for their early detection, intervention, and ultimately, eradication. This dissertation focuses on combining cutting-edge immunological, diagnostic, and computational approaches to confront infectious diseases more effectively, with a particular emphasis on SARS-CoV-2. The first two chapters delve into the immunological aspects of SARS-CoV-2, exploring the dynamics of antibody responses during primary infection and...

Event

CSB Thesis Defense: Cameron Flower (White Lab)

Posted
April 25, 2024

CSB PhD Candidate: Cameron Flower

Faculty Advisor: Prof. Forest White

Date: Friday April 26, 2024

Time: 1:00 PM EST

Thesis title: Tumor cell-intrinsic signals promoting tolerance and adaptation to oncogenic kinase inhibition

Abstract:

Therapeutics targeting oncogenic kinases have offered longer survival and superior quality of life for cancer patients with particular malignancies compared to the preceding standard of care. However, many patients still fail to show a clinically meaningful response to kinase inhibitors prescribed on the basis of tumor genotype, and nearly all responsive patients eventually develop resistance, limiting the curative potential of these agents. A more complete understanding of the molecular basis underlying therapy failure is required for designing new agents and combinations with improved...

News

Forbes Israel 30 Under 30-Liyam Chitayat

Posted
April 8, 2024

L. Chitayat| Photo: Zeno Fox

Age: 20 >> PhD student at MIT

Even before she turned 20, Liyam Chitayat began her doctorate at MIT, one of the leading academic research institutions in the US and the world, and won the Hertz Award for Research Excellence - the most...